M icroRNAs (miRs) represent evolutionary conserved small noncoding RNAs that modulate gene expression by either inhibiting mRNA translation or inducing mRNA degradation. [1] [2] [3] The miRs can be transcribed individually or in clusters and are encoded by introns or intergenic regions. After being transcribed, the primary miRs are subsequently processed by protein complexes containing the endonuclease Drosha into the precursor miR (pre-miR), which is approximately 70 nucleotides and is subsequently exported to the cytoplasm. 4 Next, the endonuclease Dicer further cleaves the pre-miR, resulting in the generation of the approximately 22-bp miR duplexes, which are incorporated in the RNAinduced silencing complex. One strand is then retained in the complex and becomes the mature miR, which binds to the 3Ј untranslated region of the target mRNA. Hundreds of miRs have been described and currently approximately 1500 miRs are considered to be expressed in humans. Each miR binds up to several hundred complementary mRNAs, thereby modulating gene expression patterns rather than single genes. In the past decade, miRs were extensively investigated and were shown to control development, tissue homeostasis, and diseases. In the cardiovascular system, miRs are known to regulate cardiac hypertrophy, apoptosis, and fibrosis, and specific miRs influence endothelial cell functions and vessel growth. 2, 4, 5 Stem/progenitor cells hold great promise in regenerative medicine and may be useful for the treatment of cardiovascular diseases (see articles of the review series). 6 Several subsets of bone marrow-derived progenitor cells have experimentally and clinically shown benefits; however, the effects have been modest and new cell types as well as strategies to improve the effects of cell therapies are currently evaluated. Particularly, the low engraftment of the applied cells and the limited (or lack of) differentiation in cardiovascular cell types were considered as major challenges of cell therapy when using adult progenitor cells. The use of embryonic stem cells (ESCs) may solve some of these issues because ESCs efficiently differentiate to all cardiovascular lineages. Recent breakthroughs in creating induced pluripotent stem (iPS) cells by overexpressing reprogramming factors such as Oct3/4, Sox2, Klf-4, and c-Myc in fibroblasts additionally allowed the generation of pluripotent stem cells that are considered as alternatives for ESCs. 7 However, several challenges need to be taken into account. 8 For example the efficiency of the iPS cell generation is rather low. Moreover, an efficient differentiation appears mandatory to exclude tumor-forming activities of contaminating pluripotent stem cells. Understanding the processes underlying programming and cell fate decisions may enable us to develop safe and efficient cell therapies or to develop strategies to potentially in vivo reprogram endogenous (stem) cells to specific lineages. Because miRs control gene expression networks, they might represent suitable tools to achieve this goal. The present overview will provide insights into the regulation of stem cell plasticity and differentiation by miRs.
MiRs and Pluripotency
MiRs are well-established to control pluripotency, selfrenewal, and differentiation of ESCs. First evidence for a crucial role of miRs for stem cell differentiation came from studies in mouse and human ESCs, in which the miR processing enzymes Dicer and Drosha or the RNA-binding protein DGCR8, which is required for the production of all canonical miRs, have been depleted. The global loss of miRs resulted in defects in differentiation and proliferation of ESCs in vitro, and Dicer-deficient mice die at early stages of development. 9 Subsequent studies showed that ESCs express a specific set of miRs 10, 11 and high-resolution ChIP-seq data demonstrated that ESC-enriched transcription factors such as Oct4, Sox2, and Nanog bind to miR promoters, thereby stimulating the expression of several miR clusters in ESCs. 12 The miR-290 cluster, which contains multiple mature miRs with seed sequences similar or identical to miR-302 or the miR-17Ϸ92 cluster, is most abundantly expressed in ESCs and comprises the majority (Ͼ70%) of miRs in undifferentiated ESCs. 12 Several members of the miR-290 cluster, namely miR-291 to 3p, miR-294 and miR-295, as well as members of the miR-302 cluster, belong to the ESC-cell cycle regulating miRs because they directly repress key regulators of the cell cycle and contribute to the unique cell cycle of ESCs. 11, 13 Specifically, ESC-cell cycle regulating miRs target multiple inhibitors of the CyclinE-Cdk2 pathway, thereby ensuring a rapid G1-S transition. 11 Of note, the miR-290 cluster is not expressed in human cells, but hsamiR-372, the orthologous to the mouse miR-294, also promotes reprogramming of human fibroblasts. 14 Beside their function in maintaining pluripotency, miRs control the differentiation of ESCs. Several miRs are specifically upregulated in ESCs after induction of differentiation to reduce the expression of pluripotency factors, a prerequisite to acquire a differentiated phenotype (Figure 1 ). For example, miR-296 represses Nanog, whereas miR-134 and miR-470 target the pluripotency factors Nanog, Oct4, and Sox2. 15 The miR-200c, miR-203, and miR-183 repress Sox2 and Klf4, 16 and miR-145 was shown to repress Oct4, Sox2, and Klf4. 17 Moreover, the downregulation of pluripotencyassociated genes such as Lin28 after induction of differentiation abolishes the block of miR processing, thereby allowing maturation of the let-7 family members, which are important for regulating the differentiation of ESCs. 18 In summary, these data indicate that miRs tightly control ESC self-renewal and differentiation pathways (Figure 1 ).
MiRs and Reprogramming
The iPS cells were first established by overexpressing the four reprogramming factors Oct3/4, Sox2, Klf4, and c-Myc in fibroblasts. 7 Several alternative combinations (eg, Oct3/4, Sox2, Nanog, Lin28) or two of the factors in other cell types (eg, Oct3/4 and Sox2) were shown to generate iPS cells. 19, 20 The iPS cells were shown to be similar, although not identical, to ESCs and showed a comparable miR expression profile. 21 On differentiation, iPS cells contributed to the formation of all cardiovascular cell lineages and their transplantation improved the recovery after acute myocardial infarction. [22] [23] [24] However, the efficiency of iPS cell generation has been rather low and the use of some of the pluripotency genes raised safety concerns. Several strategies therefore were used as alternatives for the generation of iPS cells or were developed to augment the reprogramming efficiency in combination with the aforementioned factors. 25 Based on the finding that several miRs are highly expressed in ESCs but are absent in differentiated cells such as fibroblasts, researchers attempt to mimic the ESC miR profile in fibroblasts to either facilitate the formation or directly generate iPS cells (Figure 1 ). Based on the very high expression of the miR-290 family in ESCs, first attempts were made by overexpressing members of this family in combination with Oct-4, Sox2, and Klf4 in mouse embryonic fibroblasts. 26 MiR-291-3p, miR-294, and miR-295 increase the efficiency of reprogramming, whereas the other members of the miR-290 cluster, miR-292 to 3p and miR-293, were not effective. 26 Best effects were achieved by overexpressing miR-294, which increased the efficiency to 75% of that achieved with the three reprogramming factors alone. 26 The miR-294 additionally increased the kinetics of reprogramming but was not sufficient to reprogram fibroblasts in the absence of additional reprogramming factors. 26 Moreover, overexpression of the let-7 family, which is downregulated during differentiation, promoted the dedifferentiation of somatic cells to iPS cells. 18 Members of the miR-302 family that share the same seed sequence with the members of the miR-290 cluster also enhanced the reprogramming efficiency of mouse fibroblasts 26 and the overexpression of the human miR-302 cluster in combination with miR-372 (the orthologs to the mouse miR-290 cluster members), and the reprogramming factors Oct3/4, Sox2, Klf4, and c-Myc promoted the induction of pluripotency of human fibroblasts. 14 Furthermore, the miR-302 cluster was the first shown to induce pluripotency in the absence of additional reprogramming factors in cancer cells. 27 More recently, Anokye-Danso et al, 28 for the first time showed that the overexpression of miR-302 cluster members and miR-367 directly reprogrammed mouse and human somatic cells in the absence of additional factors, and these authors reported that the combination of the miRs was more rapid and efficient compared to the classical reprogramming with the four reprogramming factors (Oct3/4, Sox2, Klf4, and c-Myc). In line with this, it was demonstrated that overexpression of the miR clusters miR-106a-363 and miR-302-367 led to an increased efficiency of iPS cell generation by accelerating the mesenchymal-to-epithelial transition. 29 Efficient reprogramming also was achieved by direct transfection of mature double-stranded miR-200c in combination with the miR-302 and miR-369 families. 30 Because this approach does not require vector-based gene therapy, it might offer a safer approach for reprogramming.
Recently, three miR clusters, namely the miR-17-92 cluster, the miR-106b-25 cluster, and the miR-106a-363 cluster, which share the same or very similar seed sequences with the miR-302 cluster members, were shown to be highly induced during reprogramming, 31 and overexpression of the miR106b-25 cluster members miR-93 and miR-106b enhanced iPS cell induction in the presence of three (Oct3/4, Sox2, and Klf4) or four (Oct3/4, Sox2, Klf4, and c-Myc) reprogramming factors. 31 The capacity of the miR-290, miR-302, miR-17, and miR-25 cluster members to enhance reprogramming in the presence of the pluripotency factors was confirmed in a recent unbiased screen of 379 miRs. 32 In this screen, the authors additionally identified the miR family miR-130/301/ 721 to augment reprogramming of fibroblasts with Oct3/4, Sox2, and Klf4. 32 The mechanisms underlying enhancement or direct induction of reprogramming by miRs remain incompletely understood and likely include targeting of various pathways, such as cell cycle and epigenetic regulators, and modulators of epithelial-mesenchymal transition. 14 Several studies suggest that the modulated expression of cell cycle regulators might have contributed to the reprogramming enhancement mediated by the miRs. Of note, among the miR-290 cluster, only those miRs that are described as ESC-specific cell cycleregulating miRs efficiently increased reprogramming, whereas other family members did not. 26 In addition, the miR-25 family members target the cell cycle inhibitor p21 31 and the miR-130/301/721 family inhibits the expression of the transcription factor Meox2, which is known to activate p21 expression. 32 Targeting of transforming growth factor-␤ (TGF␤) signaling pathways and epithelial-mesenchymal transition might additionally contribute to the miR-dependent enhancement of reprogramming. Thus, the miR-25 cluster targets the TGF␤ receptor-2 31 and miR-302/miR-372 inhibited TGF␤-induced epithelial-mesenchymal transition, 14 suggesting that inhibition of TGF␤-signaling may play a crucial role in miRfacilitated reprogramming. These findings are consistent with the fact that pharmacological TGF␤ receptor inhibitors or silencing of the TGF␤ receptor-2 augment reprogramming, whereas activation of TGF␤ reduces reprogramming. Together, these studies demonstrate that overexpression of ESC-enriched miRs can promote or induce reprogramming.
Besides mimicking ESC-enriched miR patterns in somatic cells to promote reprogramming, another approach might be to reduce the expression of those miRs, which are highly enriched in the differentiated cells used for reprogramming. Depletion of miR-21 and miR-29a, which are highly expressed in fibroblasts, modestly enhanced the reprogramming efficiency induced by Oct3/4, Sox2, and Klf4 or Oct3/4, Sox2, Klf4, and c-Myc. 33 The underlying mechanism may relate to the reduced p53 expression observed after miR-21 and miR-29a inhibition, which is known to facilitate reprogramming. Interestingly, a p53-induced miR, namely miR-34, provides a barrier for reprogramming of somatic cells. 34 However, unlike p53 deficiency, which enhances reprogramming at the expense of iPS cell pluripotency, genetic ablation of miR-34 in mouse fibroblasts promoted iPS cell generation without compromising self-renewal or differentiation. 34 In conclusion, miRs can either reduce or facilitate reprogramming and might be a safe and efficient alternative to generate iPS cells.
MiRs in Endothelial Commitment and Vascular Development
Inhibited miR processing in mice deficient for Dicer induced defects in vasculogenesis and early angiogenesis in embryos and yolk sacs, which was accompanied by an altered expression of the vascular marker proteins vascular endothelial growth factor, vascular endothelial growth factor receptor-1 and receptor-2, and Tie1. These findings indicate an essential role of Dicer for embryonic blood vessel development. 35 Likewise, in maternal zygotic Dicer mutant zebrafish, the blood circulation was disrupted. Whereas endothelial and hematopoietic precursor cells as judged from Fli1 and Scl1 expression, respectively, were overall detectable, Fli1 positive cells in the endocardium were reduced. 36 Experiments with in vitro cultivated endothelial cells confirmed that Dicer is essential for an appropriate endothelial cell function. 37, 38 However, the endothelial-restricted depletion of Dicer by crossing Dicer fl/fl mice with Tie2-Cre deletor lines did not cause embryonic lethality. 39 However, during later development, these endothelial restricted Dicer-deficient mice showed an impaired angiogenic potential in response to vascular endothelial growth factor stimulation as well as delayed wound healing and recovery after ischemia, 39 suggesting that miRs are definitively involved in postnatal vascular growth after ischemia.
Ivey et al 40 investigated which miRs were enriched in mouse ESC derived Flk-1 ϩ endothelial progenitor cells and showed a high expression of several miRs, particularly miR-126. As confirmed by subsequent studies in zebrafish and mice, miR-126 is of major importance for vascular biology because it is essential for vessel integrity and angiogenic signaling. 41, 42 In zebrafish, injection of morpholinos antisense to pri-miR-126 did not induce a gross change in morphology or patterning but reduced angiogenic response to growth factors and vascular integrity and induced hemorrhages. 41 In mice, targeted deletion of miR-126 led to a phenotype of leaky vessels, which is caused by defects in endothelial cell proliferation, migration, and angiogenesis. 42 The level of Spred1, a verified target of miR-126 and repressor of angiogenic signaling, is increased in the absence of miR-126, thereby contributing to the observed angiogenic malfunctions. The remaining surviving miR-126 deficient mice exhibited an impaired postnatal neovascularization after myocardial ischemia. 42 The lack of full embryonic lethality of miR-126 deficient mice is consistent with the finding that miR-126 per se does not have the potential to guide ESC differentiation toward the endothelial lineage in vitro. 43 Altogether, the current studies suggest that miR-126, although being enriched in the endothelial cell lineage, does not control endothelial cell differentiation and embryonic vessel formation but rather affects endothelial cell functions and integrity, for instance, by regulating the flow induced vascular remodeling 44 (Figure 2) .
The miR profiling revealed that endothelial cells that were derived from ESCs in vitro expressed the same miRs that are also enriched in endothelial cells derived from mouse embryos in vivo, namely miR-146b, miR-197, and miR-625. 41 The miR-146a has been shown to control innate immune responses, 45 but nothing is known regarding the function of these miRs in the vascular system. Kane et al 46 induced endothelial differentiation of human ESCs by making use of an embryoid body free protocol, and thereby identified miRs that were regulated during this process. The miR-126, previously described in terms of early development, and miR130a, miR-133, miR-210, miR-196, and the let-7 family were shown to be upregulated on endothelial differentiation. 46 The upregulation of the let-7 family members confirms the previously cited study demonstrating that let-7 family members are augmented during ESC differentiation to suppress pluripotency factors. 18 In mature endothelial cells, let-7f was previously shown to contribute to angiogenic sprouting of endothelial cells in vitro. 38 The other upregulated miRs, miR-210 and miR-130a, were shown to be required for angiogenic functions of endothelial cells by targeting EphrinA3 and the antiangiogenic homeobox transcription factors Gax and HoxA5, respectively. 47, 48 Interestingly, miR-130a can induce the formation of iPS cells by targeting the homeobox transcription factor Meox2, which in turn is a key regulator of reprogramming. 32 The miR-196 was shown to act upstream of Hoxb8 and Sonic hedgehog in vivo in the context of limb development. 49 The profiling of miRs during ESC differentiation to endothelial cells also revealed miRs that were downregulated during endothelial differentiation. These included miR-221 and miR-222, which were shown to repress c-kit and endothelial nitric oxide synthase, 37, 50 and miR-20a, a member of the miR-17Ϸ92 cluster. Although the function of the miR-17Ϸ92 cluster has been described in numerous physiological and pathophysiological states, 39,51,52 the specific role of the miR-17Ϸ92 cluster during endothelial differentiation is not known. A study of embryonic mice between embryonic day 13.5 and postnatal day 25 indicates an overall downregulation of the members of the miR-17-92 cluster. 53 However, the lack of an obvious vascular phenotype of miR-17-92-deficient mice (miR-17Ϸ92 Ϫ/Ϫ mice die perinatally with heart, lung, and immune defects) suggests that the miR-17Ϸ92 cluster is not essential for endothelial differentiation during embryonic development.
In summary, apart from the demonstration that several miRs are differentially expressed during endothelial differentiation in vitro and in vivo (Figure 2) , none of the miRs so far reported was shown to directly control endothelial cell fate decisions. However, a recent study provides first evidence for the regulation of endothelial diversity as it occurs in different vascular beds by miRs. Thus, increasing levels of miR-181a were shown to promote the deprogramming of lymphatic endothelial cells toward a blood vascular phenotype in vitro by targeting Prox1, the key regulator of lymphatic endothelial cell identity. 54 Recent studies showed that at least three miRs, namely miR-99b, miR-20b, and let-7b, differ between endothelial cells derived from different vascular beds. 55 Although the functional consequences of the differential expression profiles remain to be determined, the different composition of miRs was associated with changes in mRNA target gene expression and may contribute to the differential phenotype of endothelial cells in vivo.
MiRs in Smooth Muscle Differentiation
The role of the miR-processing enzyme Dicer in smooth muscle development and function was studied by using mice with a floxed Dicer allele that were bred to smooth muscle cell (SMC)-specific SM22a Cre recombinase expressing mice. Mutant mice die at embryonic day 16 to embryonic day 17 because of intraperitoneal bleeding and impaired SMC contractility, 56 showing that Dicer dependent miRs are essential for the development of SMCs. Likewise, depletion of Dicer in the proepicardium by a Gata5 Cre recombinase transgenic line resulted in defects in the epicardial epithelialto-mesenchymal transition and the differentiation of SMCs, which led to perinatal death. 57 SMCs are profoundly regulated by miR-145 (Figure 2 ), a miR that is cotranscribed together with miR-143. During development, the expression of this pair of miRs is confined to SMCs. 58 -60 The miR-143/miR-145 expression is controlled by serum response factor and its coactivator, myocardin, and these miRs target a network of transcription factors, including Klf4 and Elk-1, as well as a number of cytoskeletal proteins and the angiotensin-converting enzyme. 58 -60 Importantly, the vascular defects observed in SMC restricted Dicer deficient mice were partially rescued by overexpression of miR-145, 56 demonstrating an essential role of this miR during SMC development. In addition, overexpression of miR-145, but not miR-143, was sufficient to direct differentiation of multipotent neural crest stem cells into SMCs in vitro. 58 In ESC derived SMC precursors, overexpression of miR-145 induced a more mature phenotype associated with increased expression of contractile proteins. 61 However, loss of miR-145 did not fully inhibit the formation of SMCs but resulted in a different SMC phenotype that resembles the synthetically proliferating SMCs in vascular lesions. 58 Consistently, knockout mice lacking either miR-145 or the combination of miR-143 and miR-145 are viable and show no overt abnormalities in smooth muscle differentiation. 59, 60 However, neointima formation after vessel injury was reduced in miR-145 Ϫ/Ϫ mice and to a lesser extent in miR-143 Ϫ/Ϫ mice. 59 Conversely, overexpression of miR-143 and miR-145 decreased neointima formation, 62 suggesting that miR-143 expression and miR-145 expression tightly control the SMC response of vessels after injury. Moreover, blood pressure was reduced and atherosclerotic lesion development was enhanced in miR-143/145 deficient mice. 59, 60 Although these data indicate that miR-143 and miR-145 play crucial roles in regulating the SMC phenotype, they seem not to be essential for the differentiation of stem cells to the SMC lineage in vivo. In vitro, these miRs augment SMC differentiation and maturation under certain conditions.
Recent studies suggest that miR-1, which has been studied in cardiac differentiation, also plays a role in SMC differentiation. 63 The miR-1 expression is steadily increased during differentiation of mouse ESCs to SMCs. Loss-of-function approaches using miR-1 inhibitors uncovered that miR-1 is required for SMC lineage differentiation in ESC derived SMC cultures, as evidenced by the downregulation of SMC specific markers and the decrease of the derived SMC population. The miR-1 also regulated the transcription factor KLF4, 63 which was previously identified as miR-145 target. 58 The miR profiling additionally showed that miR-10a is increased during retinoid acid-induced SMC differentiation from ESC and inhibition of miR-10a blocks SMC differentiation. 64 The miR-10a was shown to target HDAC4; 64 however, the causal involvement of miR-10a dependent repression of HDAC4 in SMC differentiation remains to be determined.
MiRs and Cardiac Differentiation
The miRs play key roles in emergence and maintenance of the differentiated state of cardiac myocytes but are critical regulators of cardiac pathologies. 2, 65 The miR profiling of cardiomyocytes derived from human ESCs revealed that, among others, the "myomiRs" miR-1, miR-133, miR-208, and miR-499 were significantly changed during cardiac differentiation. 40, 66, 67 The miR-1 and miR-133 are critical regulators of muscle proliferation and differentiation 68 (Figure 2) . The miR-1-1 and miR-1-2 represent two alleles of one gene and are specifically expressed in cardiac and skeletal muscle precursors, and overexpression of miR-1 in fibroblasts shifts their gene expression profile toward that of muscle cells. 69 Overexpression of miR-1 in mice led to developmental arrest at embryonic day 13.5, thin-walled ventricles and heart failure attributable to reduced myocyte proliferation, 70 and targeted deletion of one of the two miR-1 genes (miR-1-2), resulted in numerous failures, including defective morphogenesis, electrical conduction, and dysregulated cell-cycle control in the heart. 71 In line with this, loss-of-function and gain-offunction studies in Drosophila demonstrated a role for miR-1 in modulating cardiogenesis and muscle-gene expression. 72 In vitro, miR-1 acts as a potent repressor of nonmuscle genes and its overexpression increased the expression of Nkx2.5, one of the earliest cardiac markers, during mouse and human ESC differentiation. 40 In human ESC derived embryoid bodies, miR-1 overexpression also increased myosin heavy chain genes. 66 Likewise, miR-1 accelerated the occurrence of beating areas and increased cardiac marker genes in adult cardiac progenitor cells. 67 Interestingly, mouse ESCs that were overexpressing the precursor of miR-1 were transplanted into the border zone of infarcted mouse hearts and were able to protect the myocardium from ischemia-induced apoptosis, suggesting that miR-1 promotes ESC differentiation into the cardiac lineage in vivo. 73 However, other studies did not detect such an induction of cardiac gene expression by lentiviral delivery of miR-1 in a two-dimensional mouse ESC culture. 74 Therefore, it is conceivable that miR-1 fine-tunes the complex balance between proliferation and differentiation and therefore may elicit distinct effects depending on the exact timing and the specific assays used to analyze cardiac differentiation. In addition, miR-1 was suggested to control electrophysiological maturation of ESCs. 75 Direct targets of miR-1 that might be involved in the regulation of cardiac differentiation include the transcriptional repressor of muscle gene expression HDAC4, 68 the Notch ligand Delta-like 1, 40 and Hand2, a transcription factor regulating the myocyte expansion. 71 The miR-1 and miR-133 are polycistronically clustered on the same chromosome and therefore are transcribed together. However, they do not share identical functions and even play opposing roles during proliferation and differentiation of muscle precursors. Single deletion of either of the miR-133a genes yielded phenotypically normal mice, whereas deletion of both miR-133a genes resulted in late embryonic or neonatal lethality attributable to ventricular septal defects and abnormalities in cardiomyocyte proliferation. 76 In contrast to miR-1, which induced the expression of mesodermal and cardiac marker genes, 40 overexpression of miR-133 in mouse and human ESCs repressed cardiac markers, 40, 74 and miR-133 overexpressing myoblasts displayed increased proliferation caused by repression of serum response factor and cyclin D2. 68, 76 In summary, the observation that miR-1 and miR-133 have counteracting features implicates the presence of mechanisms regulating these miRs on the posttranscriptional level, eg, through regulation of miR processing or stability. Of note, the function of the cluster is not limited to developmental stages, but these miRs are dysregulated in cardiac disease and were shown to regulate hypertrophy in some but not all studies, and miR-133 was reported to modulate electric repolarization after transverse aortic constriction. 2, 77 Further studies showed that miR-499 was enriched in cardiac committed adult cardiac progenitor cells 67 and human ESCs. 66 The miR-499 is encoded by an intron of the myosin heavy chain 7B and shares many predicted targets with miR-208, which is encoded by an intron of the alpha myosin heavy chain gene and plays a crucial role in stress-adaptation of the adult heart. 65 Overexpression of miR-499 reduced the proliferation of cardiac progenitor cells and accelerated the formation of beating embryoid bodies. 67 In addition, the expression of myosin heavy chain genes and the cardiac transcription factors were elevated in mouse and human ESC cultures indicative for an augmentation of cardiac differentiation and the maintenance of the differentiated state in vitro. 66, 75 Vice versa, inhibition of miR-499 blocked cardiac differentiation, 67 demonstrating that miR-499 controls cardiac commitment in vitro. In vivo, overexpression of miR-499 in human cardiac stem cells resulted in an enhanced myocyte differentiation when implanted into the border zone of infarcted rat hearts. 78 Finally, mice lacking the entire miR-17-92 cluster exhibited defects in cardiac development. 79 When the knockout of miR-17-92 was combined with the deletion of the paralogous clusters miR-106-25 or miR-106-363, compound mutant embryos die during mid gestation. 79 However, the cardiac phenotype of the mice has not been thoroughly studied and the specific functions of the miR-17-92 cluster members in cardiac differentiation and development are unclear.
MiRs in Adult Progenitor Cells
The miRs not only regulate ESC differentiation and reprogramming but also control adult stem/progenitor cell functions. Although for a long time the heart had been considered to consist exclusively of terminally differentiated cells, today it is known that several classes of cardiac stem and progenitor cells exist in the adult heart of most species. 80, 81 Still, little is known with respect to the control of cardiovascular progenitor cell functions by miRs. Some miRs, such as miR-1, were shown to regulate cardiac progenitor cell and myoblast proliferation, and miR-499 induced the differentiation of c-kit ϩ cardiac stem cells. To identify miRs that may control proliferation of cardiac progenitor cells, Sirish et al 82 compared the expression of miRs in cardiac progenitor cells isolated from neonatal versus adult mice and showed that miR-17, a member of the miR-17-92 cluster, was reduced in adult compared to neonatal progenitor cells. Interestingly, overexpression of the miR-17-92 cluster in adult cardiac progenitor cells led to an increased proliferation rate, 82 a finding that is consistent with the high expression of the cluster in undifferentiated ESCs.
Furthermore, Hu et al 83 overexpressed a miR prosurvival cocktail composed of miR-21, miR-24, and miR-221 to improve the engraftment of transplanted cardiac progenitor cells. The combined expression of these miRs enhanced the therapeutic efficacy for treatment of ischemic heart diseases. 83 Moreover, the first studies suggest that miRs control circulating blood-derived or bone marrow-derived cells. Bone marrow-derived and blood-derived hematopoietic and endothelial progenitor cells promote neovascularization and repair. 6 However, cardiovascular risk factors and aging were shown to impair the functions of this endogenous pool of proangiogenic cells. 84, 85 The functional impairment of these cells in patients with coronary artery disease was associated with an increased expression of miR-21 86 and a dysregulation of other vascular miRs. 87 Interestingly, antagonizing miR-21 led to an improved functionality of proangiogenic cells from patients with coronary artery disease who otherwise experienced oxidative stress mediated by an upregulation of miR-21 in this disease state. 86 Mechanistically, Fleissner et al 86 showed that asymmetrical dimethylarginine, which inhibits nitric oxide production and is elevated in patients at risk for coronary artery disease, increases the expression of miR-21 in proangiogenic cells, resulting in a reduction of sprouty-2 and superoxide dismutase-2, and finally leading to an impaired migratory capacity of the cells. Moreover, overexpression of miR-34a was shown to induce endothelial progenitor cell senescence in vitro by repressing the histone deacetylase SIRT1. 88 
Conclusions
Increasing evidence suggests that miRs play a crucial role in regulating cell renewal and differentiation. The repression of patterns of genes likely contributes to lineage commitment. However, because knockout of single miRs often does not affect embryonic development, one may speculate that miRs are involved in the fine-tuning rather than in making "on/off" decisions. An alternative explanation for the lack of embryonic lethality is that miRs might be compensated by family members, which often differ in only a few nucleotides. Despite these open questions, several studies suggest that overexpression of specific miRs facilitates lineage commitment of stem cells. These miRs may be useful for stimulation of cell fate decisions in vitro and might potentially be used for in vivo direct reprogramming of adult progenitor cells or somatic cells to specific cell lineages. Most importantly, the recent findings showing that combinations of miRs are sufficient to induce reprogramming open new possibilities for the safer generation of iPS cells. In addition, miRs may be useful to block apoptosis and to activate the functional activities of applied progenitor cells.
